SignPath Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SignPath Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10532
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SignPath Pharma Inc (SignPath) is a developer of therapeutics based on its pure synthesized curcumin compounds. The company’s curcumin compounds acts as an anti-oxidant, anti-inflammatory and anti-cell recycling agent. It develops curcumin based products in different intravenous nanoparticle-sized formulations such as liposomal, polymeric and PLGA. SignPath’s products find application in the treatment of cancers, neurologic disorders and mitigate drug-induced cardiac arrhythmia. The company conducts clinical trials for non-small cell lung cancer. It partners with laboratories, hospitals, and other companies in Canada, Europe, the US, and Asia. SignPath is headquartered in Quakertown, Pennsylvania, the US.

SignPath Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SignPath Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
SignPath Pharma to Acquire Patent Rights to Cardiac Arrhythmia Mitigation Drugs from Annie Bouchard 10
Venture Financing 11
SignPath Pharma Raises Additional USD2 Million in Financing Round 11
SignPath Pharma Raises USD0.3 Million in Financing Round 12
Licensing Agreements 13
SignPath Pharma Enters into Licensing Agreement with University of North Texas Health Science Center 13
SignPath Pharma Enters into Licensing Agreement with University of North Texas 14
Equity Offering 15
SignPath Pharma Raises USD3.3 Million in Second Tranche of Private Placement of Shares 15
SignPath Pharma Completes First Tranche Of Private Placement For US$1 Million 16
SignPath Pharma Completes Second Tranche Private Placement Of Series B Convertible Preference Stock For US$0.7 Million 17
SignPath Pharma Inc – Key Competitors 18
SignPath Pharma Inc – Key Employees 19
SignPath Pharma Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SignPath Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SignPath Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SignPath Pharma to Acquire Patent Rights to Cardiac Arrhythmia Mitigation Drugs from Annie Bouchard 10
SignPath Pharma Raises Additional USD2 Million in Financing Round 11
SignPath Pharma Raises USD0.3 Million in Financing Round 12
SignPath Pharma Enters into Licensing Agreement with University of North Texas Health Science Center 13
SignPath Pharma Enters into Licensing Agreement with University of North Texas 14
SignPath Pharma Raises USD3.3 Million in Second Tranche of Private Placement of Shares 15
SignPath Pharma Completes First Tranche Of Private Placement For US$1 Million 16
SignPath Pharma Completes Second Tranche Private Placement Of Series B Convertible Preference Stock For US$0.7 Million 17
SignPath Pharma Inc, Key Competitors 18
SignPath Pharma Inc, Key Employees 19

List of Figures
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SignPath Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SignPath Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Demant AS (DEMANT):企業の財務・戦略的SWOT分析
    Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Paddy Power Betfair Plc
    Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report Summary Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Carlsberg AS (CARL B):企業の財務・戦略的SWOT分析
    Carlsberg AS (CARL B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ur-Energy Inc (URE):企業の財務・戦略的SWOT分析
    Ur-Energy Inc (URE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Trinity Industries, Inc (TRN):電力:M&Aディール及び事業提携情報
    Summary Trinity Industries, Inc. (Trinity) is a diversified industrial company. It produces and supplies railcars and railcar parts, inland barges, aggregates and highway products. It also manufactures tank containers, steel parts and structural wind towers. It also offers services such as railcar f …
  • Achira Labs Pvt Ltd:企業の製品パイプライン分析2018
    Summary Achira Labs Pvt Ltd (Achira Labs) is an immunodiagnostics company that develops diagnostics solutions for developing countries. The company offers ACIX100, a microfluidics platform that combines a plastic disposable cartridge containing dry reagents and a desktop reader instrument. Its ACIX …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • FitLife Brands Inc:企業の戦略・SWOT・財務情報
    FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report Summary FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Shire plc:企業のM&A・事業提携・投資動向
    Shire plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shire plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Toyo Seikan Group Holdings, Ltd.:企業の戦略・SWOT・財務分析
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Tel Aviv Sourasky Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Tel Aviv Sourasky Medical Center (Sourasky Medical) is an academic medical center that provides patient-centered care, research and education services. The center offers services in the areas of cardiology, dermatology, gastroenterology, general surgery, genetics, emergency medicine, rheumat …
  • Sensus Healthcare Inc (SRTS):企業の財務・戦略的SWOT分析
    Sensus Healthcare Inc (SRTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Rowan Companies plc:企業の戦略・SWOT・財務分析
    Rowan Companies plc - Strategy, SWOT and Corporate Finance Report Summary Rowan Companies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Amathus Public Ltd:企業の戦略・SWOT・財務情報
    Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kansas Electric Power Cooperative, Inc.:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Stobart Group Ltd (STOB):企業の財務・戦略的SWOT分析
    Stobart Group Ltd (STOB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GE Healthcare:企業の戦略・SWOT・財務分析
    GE Healthcare - Strategy, SWOT and Corporate Finance Report Summary GE Healthcare - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CorEnergy Infrastructure Trust Inc (CORR):企業の財務・戦略的SWOT分析
    CorEnergy Infrastructure Trust Inc (CORR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Bruker Daltonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bruker Daltonics Inc (Bruker Daltonics), a subsidiary of Bruker Corp, is a medical device company that manufactures scientific instruments for molecular and materials research, and for industrial and applied analysis. The company's products include mass spectrometry and separations, preclini …
  • Secom Co Ltd (9735):企業の財務・戦略的SWOT分析
    Secom Co Ltd (9735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆